JANUARY 2022 PRICE HIKES REPORT: A New Year Brings The Same Old Bad Behavior By Big Pharma
The report demonstrates why urgent congressional action is needed to address Big Pharma’s abusive pricing practices.
The report demonstrates why urgent congressional action is needed to address Big Pharma’s abusive pricing practices.
"Patients are counting on Congress and the Biden administration to deliver drug pricing reforms immediately in this new year."
The Build Back Better Act “Will Make Our System Work Better For Those It Is Intended To Serve: Patients And All Americans”
Government And Taxpayers Saved The Day; Drug Corporations Did Their Job, Then Cashed In
Patients For Affordable Drugs Responds To The Industry’s $18 Million Attack Ads Aimed At Thwarting Reforms To Lower Drug Prices
The FDA’s approval of Semglee as an interchangeable biosimilar to Lantus is an important step forward on the road to real competition.
Patients For Affordable Drugs’ Analysis Highlights Need For Medicare Negotiation For All Drugs
P4AD analyzed the wholesale acquisition cost (WAC) data for the 170 unique National Drug Codes (NDCs) with price hikes greater than 1% or $1 that were posted between July 1 and July 6.
Patients For Affordable Drugs is the only independent national patient organization focused exclusively on achieving policy changes to lower the price of prescription drugs.